.

Patricia A. Lafferty

Portrait of Patricia A. Lafferty

Patricia has 20 years of litigation experience, with approximately 10 years of focus solely on the defense of health care providers. She represents physicians, nurses, advanced practice providers, physician practice groups, hospitals and skilled nursing facilities in medical malpractice and skilled nursing lawsuits. As a seasoned litigator, Patricia successfully represents her clients in all stages of litigation through trial, settlement negotiations and/or alternative dispute resolution including mediation and arbitration. Patricia also has experience handling legal malpractice cases as well as product liability matters.

Patricia developed and honed her trial skills early in her career while working as a prosecutor in the Lackawanna County District Attorney’s Office, where she tried multiple felony and misdemeanor cases. She was also an Assistant City Solicitor for the City of Scranton, where she worked closely with the Mayor of Scranton and her Administration.

An active member of the local legal community, Patricia serves on the Board of Directors for the Lackawanna Bar Association. She is also past President of the Young Lawyers Division and earned the prestigious Peggy Gavin Award.

    • Widener University Delaware Law School (J.D., 2003)
    • University of Scranton (B.S., 1996)
    • Pennsylvania, 2003
    • Lackawanna Bar Association Peggy Gavin Award
    • Northeast Child Advocate Award presented by the Children's Advocacy Center of Northeastern PA
    • Lackawanna County Bar Association, Board of Directors (2022); past president of Young Lawyers Division
    • Pennsylvania Bar Association

Thought Leadership

The Quarterly Dose

“IYKYK” – Keeping Up to Date with Social Media

May 1, 2025

If you know, you know! Social media has become ubiquitous and continues to evolve into myriad platforms. As the chaos surrounding a threatened shutdown and brief outage of TikTok illustrated in January 2025, most people believe that they cannot and simply do not want to live without it. Since Facebook was founded in 1996, social media has reached over half the world’s population. In 2010, there were 970 million active social media users globally. That number has ballooned to 5.24 billion users in January of 2025. In the United States, 70.1% of the total population actively use social media. Amazingly, Americans spend an average of 2 hours and 9 minutes on social media every day. With these staggering numbers in mind, it would be naïve to think that social media does not play a role in litigation and the discovery process.  Ethical and Technological Considerations  When it comes to social media users, research has shown that there are stark differences in not only the generational usage of the various types of social media, but gender differences as well. It should be no surprise that age has an effect on usage. According to DataReportal, a website that provides global digital insights and trends, recent usage numbers show that everyone is embracing social media and all that it has to offer, with 84% of 18- to 29-year-olds and 45% of those aged 65 and older using social media. Additional research demonstrates that in the United States, females are more prevalent and account for 78% of social media users, whereas 66% of men use social media. Women were noted to use platforms such as Snapchat and Pinterest, and men tend to favor sites like YouTube and X(Twitter). According to a recent article by Exploding Topics, YouTube is the world’s most popular and widely used social media platform, followed by Facebook, Instagram, WeChat, Reddit, Messenger, TikTok, Telegram and Viber. These statistics can be a useful guide in directing you to where your target audience is spending their “down” time, leading to more pointed additional discovery requests. Due to the vast amount of information and data being generated by each user, it is important to cater your discovery requests to get as much information without going down the rabbit hole of what could be mountains of documentation and paperwork. Keeping up to date on the research related to ever-changing social media trends and the various demographics can help to narrowly tailor your discovery requests and yield pertinent information to defend your case. It is important to keep in mind that the Rules of Professional Conduct require attorneys to “keep abreast of changes in the law and its practice, including the benefits and risks associated with relevant technology.” (Pa. R.P.C. 1.1.). The obligation also exists for lawyers to ensure that preservation of such discoverable materials is maintained at the risk of spoliation issues arising. In 2014, the Pennsylvania Bar Association adopted the view of the Philadelphia Bar Association Professional Guidance Committee that a lawyer may advise a client to change the privacy settings on the client’s Facebook page, however, a lawyer “may not instruct or permit the client to delete/destroy a relevant photo, link, text, or other content, so that it no longer exists.” (Pa. Bar Ass’n Formal Op. 2014-300 [Sept. 2014]). The same principles still apply today, and lawyers are required to take affirmative steps to preserve social networking evidence and advise client(s) of the same.  Since social media discovery has to be maintained by the party, considerations can and should be given for an individual to preserve their own account. Many social media sites are now on the second and third generation of these platforms, and technological advances have allowed access to more features that may not have been feasible at their inception. For example, many platforms now allow individual users to download their entire account in just a few steps. Social media powerhouses such as Facebook, Instagram and TikTok all offer this feature. This process can be accomplished, in some circumstances, in a few “clicks” and arguably alleviates the “overly burdensome” obstacle of Pennsylvania Rule of Civil Procedure 4011.  What the Courts Have to Say  Under the general discovery principals in Pennsylvania, information contained on a litigant’s social media platforms is generally discoverable. In Pennsylvania, “…a party may obtain discovery regarding any matter, not privileged, which is relevant to the subject matter involved in the pending action, whether it related to the claim or defense of the party seeking discovery or to the claim or defense of any other party, including the existence, description, nature, content, custody, condition, and location of any books, documents, or other tangible things and the identity and location of persons having knowledge of any discoverable matter.” (Pa.R.C.P. 4003.1.) Pennsylvania Rule of Civil Procedure 4009.1 explicitly permits the discovery of electronically stored information. This broad general principle of what is discoverable is limited by Pennsylvania Rule of Civil Procedure No. 4011, which states: “No discovery, including discovery of electronically stored information, shall be permitted which (a) is sought in bad faith; (b) would cause unreasonable annoyance, embarrassment, oppression, burden or expense to the deponent or any person or party; … or (e) would require the making of an unreasonable investigation by the deponent or any party or witness.”  Despite the popularity and extensive use of social media platforms, Pennsylvania Appellate Courts have not yet addressed the parameters of what is discoverable, and appellate review is scant. The trial courts, however, have seen their fair share of attempts to widen and/or limit the net of discoverable data. The court’s interpretations have been varied when it comes to how far litigants can go when delving into the world of social media discovery. Most courts have treated social media information as they would any other information sought in discovery. In Brogan v. Rosenn, Jenkins & Greenwald, LLP, the court stated:  Consistent with that firmly established discovery maxim, a party may obtain discovery of private Facebook posts, photographs and communications only if the electronically stored information is relevant, and the party must satisfy that relevancy requirement by showing that publically accessible information posted on the user’s Facebook page controverts or challenges the user’s claims or defenses in the pending litigation. To that extent, the resolution of social media discovery disputes pursuant to existing Rules of Procedure is simply new wine in an old bottle.  (C.C.P. Lackawanna April 22, 2013) (Nealon, J.). Moreover, in at least in one case, the court held that it was not necessary for a party to have a public profile before the opposing party is given access to the private portion of a party’s social media profile. In Arcq v. Fields, No. 11-4637 (C.C.P. Franklin Dec. 7, 2011) (Herman, J.), the defendants’ Motion to Compel information about the plaintiff’s social networking sites was denied due to the defendants’ failure to show any reasonable basis for believing access to the plaintiff’s profiles would yield any relevant information. Despite the denial of the motion, the court took a broad view of what the defendants had to show prior to being given access to the plaintiff’s private profile, stating: “[w]hile it is not an absolute necessity that a plaintiff have a public profile before a defendant can be given access to the private portion, it is necessary that defendant have some good faith belief that the private profile may contain information.” Arcq v. Fields, No. 11-4637 (C.C.P. Franklin Dec. 7, 2011) (Herman, J.).  Privacy Settings Privacy considerations are typically the main argument against disclosure of a litigant’s “private” social media information as based on the individual’s privacy rights. While the privacy argument has been rejected by Pennsylvania trial courts in some circumstances, most litigants will continue to push back when discovery seeks specific information that is contained on a litigant’s “private” social media platforms.  When discovery seeks information contained within a litigant’s private social media platforms, Pennsylvania trial level courts have implemented a balancing test that balances the need for relevant “private” social media information and the parties’ privacy concerns. In Hunter v. PRRC, Inc., 2013 WL 9917150 (York C. C. P. Nov. 4, 2013) (Linebaugh, J.), the court determined that a party making the request for social media information must make:  [A] threshold showing that otherwise available information leads to the reasonable probability that relevant information is contained with the private portions of the account. The hypothetical possibility that relevant information may exist in any account held privately is not sufficient to meet this showing. Actual facts must be shown…  A “threshold showing” is the standard for Pennsylvania Courts in deciding whether private social media information should be disclosed in discovery; however, the analysis does not end at this showing. In Trail v. Lesko, 2012 WL 2864004 (Allegheny C. C. P. July 3, 2012) (Wettick, J.), the court analyzed the approaches taken by nine earlier Pennsylvania trial courts and recognized that discovery of private social media information is inherently intrusive and, relying on Pa.R.C.P. No. 4011, noted a court should consider the “level of the intrusion and the potential value of the discovery to the party seeking discovery.” Most recently in Allen v. Sands Bethworks Gaming, LLC, 2018 WL 4278941 (Northampton C. C. P. Aug 6, 2018) (Dally, J.), the court found that in order to obtain the private portions of a litigant’s social media information, the requesting party must show discrepancies between the public portions of the litigant’s social media platforms and what the litigant is claiming in the lawsuit. These considerations, as to whether your case will cross the threshold, should be considered in any motion to compel. It is evident that social media discovery exploration is a necessary component to ensure that you are properly defending your clients. Preparing discovery that is geared toward the opposing party’s use of various social media platforms helps to maintain the most effective use of your and your client’s time. Understanding the court’s parameters of what is permissible and whether your case will meet the privacy threshold will help you successfully navigate the inevitable discovery disputes.     The Quarterly Dose – May 2025, has been prepared for our readers by Marshall Dennehey. It is solely intended to provide information on recent legal developments and is not intended to provide legal advice for a specific situation or to create an attorney-client relationship. We welcome the opportunity to provide such legal assistance as you require on this and other subjects. If you receive the alerts in error, please send a note to tamontemuro@mdwcg.com. ATTORNEY ADVERTISING pursuant to New York RPC 7.1. © 2025 Marshall Dennehey. All Rights Reserved.

Firm Highlights

Result

No-Cause Jury Verdict Secured in Wrongful Death Trial

We successfully obtained a no-cause jury verdict in a 13-day wrongful death trial. The decedent, a 59-year-old man, was admitted to the emergency room on February 15, 2019, with complaints of abdominal pain, decreased appetite, and constipation, despite the use of laxatives. The patient did not complain of any nausea, vomiting, or diarrhea. He had a significant medical history including diabetes, hypertension, prior coronary artery stenting, morbid obesity (with past gastric bypass surgery), longstanding ventral hernia, and back pain. A CT scan revealed multiple hernias and a potential closed-loop bowel obstruction, leading to a surgery consultation. Our client, an emergency general surgeon, interpreted that the patient did not have a closed loop or any significant obstruction and recommended non-surgical management. The patient was approved to have clear liquids, and had a vomiting incident shortly after, but our client was not notified. The patient was returned to NPO status, and after improving overnight, he was returned to “clears” and additional medical and renal consults were ordered. Our client did not receive any communications from the residents/nurses of any changes in the patient’s condition. On February 18, 2019, two rapid responses were called due to increased heart rate and vomiting. It is believed that the vomiting resulted in aspiration, causing sepsis, ultimately leading to the patient’s death. During the trial, the plaintiff’s sole medical expert highlighted imaging on the wrong hernia, which called into question all of his opinions in the case. We made key objections related to the expert testimony, limiting what the allegations were, and preventing new allegations from being made. After approximately two and a half hours of deliberating, the jury returned a no-cause verdict. 

News

Marshall Dennehey’s John J. Hare Brings Home Attorney of the Year Honors; Firm Named Litigation Department of the Year in Two Categories

Marshall Dennehey took home top honors in three categories at the The Legal Intelligencer’s 2026 Pennsylvania Legal Awards, held June 11 in Philadelphia. The first place awards include: Attorney of the Year: John J. Hare, Chair of the firm’s Appellate Advocacy & Post-Trial Practice Group and Executive Committee member, together with Charles “Chip” Becker of Kline & Specter Litigation Department of the Year, Appellate – Third Win in a Row! Litigation Department of the Year, Product Liability/Mass Torts “There is no one more deserving of Attorney of the Year honors than John. This award is a testament to his exceptional skill, dedication, and leadership—qualities that truly exemplify the very best of our firm,” said G. Mark Thompson, Marshall Dennehey’s President & CEO. “These honors also reflect the strength and depth of our product liability, mass torts, and appellate practices across Pennsylvania and beyond, underscoring our ongoing commitment to delivering outstanding results for our clients.” Attorney of the Year – John J. Hare, Marshall Dennehey, together with Charles “Chip” Becker, Kline & Specter Over the past year, John and Charles were opposing counsel in many of the highest-profile civil appeals in Pennsylvania. John is renowned as a preeminent appellate lawyer on the defense side, and Chip on the plaintiff's side. They have opposed each other repeatedly, exhibiting peerless professionalism and exceptional civility, while zealously litigating under the unremitting pressure of high-profile litigation and record-setting verdicts totaling more than $3.5 billion. They have also collaborated, outside of litigation, on many commissions, committees, and projects of importance to the Pennsylvania judiciary and legal community. Litigation Department of the Year – Appellate Law, Winner (previous winner, 2025 and 2024) 2025 was another standout year for the firm’s Appellate Advocacy & Post‑Trial Practice Group, led by John J. Hare, which was retained to challenge many of Pennsylvania’s “nuclear” verdicts—awards exceeding $10 million. Notably, the department persuaded the Pennsylvania Superior Court to reverse a Philadelphia judgment of $1.09 billion, the largest judgment ever overturned by a Pennsylvania appellate court. The group’s 11 full‑time Pennsylvania‑based appellate lawyers are at the center of Pennsylvania’s most high-profile matters, bringing more than 150 years of combined appellate experience. They routinely handle post‑trial and appellate matters and are frequently engaged to participate in and monitor trials in high‑exposure cases to ensure that critical legal issues are properly raised and preserved for appeal. Litigation Department of the Year – Product Liability/Mass Torts, Winner This marks the first win for the firm’s Pennsylvania Product Liability and Mass Torts practices, which operate within our Casualty Department, managed by Matthew Schorr and Jeff Rapattoni. For almost five decades, Fortune 500 product manufacturers/distributors and their insurers have turned to these groups to defend their litigation. Led by Bradley D. Remick and Vlada Tasich, our Product Liability group’s success can be attributed to its commitment to keeping abreast of ever-changing legal theories, judicial viewpoints, and evolving technology impacting the product liability landscape. Our attorneys have successfully handled thousands of product liability matters in all jurisdictions across the state. Likewise, our mass tort litigation practice – divided into Asbestos & Mass Tort, and Environmental & Toxic Tort Litigation –  has defended manufacturers, distributors, contractors, and premises owners in thousands of personal injury and other claims. Led by Kevin E. Hexstall and Patrick T. Reilly, most attorneys in these groups have more than 20 years of experience, and our seasoned trial team has tried hundreds of cases to verdict, consistently achieving strong results through both trials and settlements. In addition to these awards, Marshall Dennehey was a Litigation Department of the Year finalist for Professional Liability.

Thought Leadership

SIDEBAR: News and Happenings

We are pleased to share that attorneys from our health care team have been selected to the 2026  New Jersey and Pennsylvania Super Lawyers and Rising Stars lists. Their dedication to clients and commitment to high-quality work continues to strengthen our firm! Please join us in congratulating: NJ Super Lawyers: Robert T. Evers and Justin F. Johnson NJ Super Lawyer Rising Stars: Nataliana A. Guida  2026 Pennsylvania Super Lawyers: Alyson J. Kirleis and Gary M. Samms 2026 Pennsylvania Rising Stars: Holli K. Archer and Daniel Dolente Victoria Scanlon (Scranton) was a faculty presenter at the 2026 American Roentgen Ray Society (ARRS) Annual Meeting in Pittsburgh. She participated in the “Resident Symposium: Producing Quality Reports,” focusing her presentation on “How to Write a Great Report: Malpractice Lawyer’s Perspective.” Vicky, the only attorney presenter for this two-hour segment, was joined by several health care professionals including diagnostic radiologists, an interventional radiologist, an internal medicine physician, and a radiologist turned AI entrepreneur expert.  Matthew Keris (Scranton), President of the Pennsylvania Association for Health Care Risk Management (PAHCRM) and shareholder in our Scranton Health Care Department, presented an important and timely session titled “Keynote Address: A Conversation with RaDonda Vaught on Criminalizing Errors” at PAHCRM’s Annual Meeting in April. RaDonda is a former Tennessee nurse widely known for being criminally convicted in 2022 of negligent homicide and gross neglect after a 2017 fatal medication error at Vanderbilt University Medical Center. Her case gained national attention because she was criminally prosecuted rather than just facing licensing board action, sparking debate over blaming individual nurses for systemic healthcare failures. Matt and RaDonda’s conversation explored one of the most consequential issues in health care risk management today—how systems respond to human error, and what it means for patient safety, accountability, and the professionals who serve on the front lines. Gary Samms was a panelist for a podcast hosted by the Medical Liability Monitor, “From Outliers to Pattern: The Increasing Predictability of Megaverdicts in the Med-Mal Industry – and How to Reduce the Likelihood of Getting Hit with One.” Gary discussed the changing megaverdict landscape and why “outlier” verdicts are becoming structural, in addition to how plaintiffs turn weaknesses into megaverdicts (including building emotional narrative and jury psychology). Thank you to our clients who joined us for our Trends in Health Care & Health Law seminar on May 14. Led by our Health Care Department Director and Assistant Director, Robin Snyder and Donna Modestine, the session explored key issues that are currently shaping outcomes in health care litigation. We owe a debt of gratitude to our esteemed guest speaker, Mary Ellen Nepps, Esq., Senior Counsel, University of Pennsylvania, who presented “Medical Malpractice Litigation: Driving Another Health Care Crisis in Pennsylvania.” And special thanks to our attorneys who presented and shared their insights, including John J. Hare and Holli Archer who discussed “Highlights in PA Medical Malpractice Law;” David Drake for his presentation, “From Claims to Courtroom: Key Trends in NJ Medical Malpractice Litigation;” and Matthew Keris with an “Update on Health Care Tech Discovery.” Thank you to all of our clients for entrusting us with your health care litigation. We are proud to partner with you as we defend your interests and navigate legal landscapes together.

Thought Leadership

Casual Care, Serious Consequences: How Informal Prescribing Can Trigger Medical Board Scrutiny

The lesson for health care practitioners is that regular review of the regulatory requirements can ensure compliance and that casual prescribing may be in violation of state regulations if the necessary components are not met. Consider the following scenario: in December 2025, a medical provider renewed a prescription for a long-standing telemedicine patient receiving a Schedule II controlled dangerous substance. This was not a violation of the New Jersey Administrative Code. Another provider doing the same action for an equally situated patient in March 2026 would be in violation. The casual prescriber who is not aware of newer regulatory requirements may have a more difficult time responding to a medical board complaint. Medicine is a highly-regulated helping profession. Without addressing the merits of this regulatory burden, the practice of medicine continues to see drastic changes impacting the everyday life of patient and provider. Telemedicine, COVID-19, and other advances and roadblocks, present a challenge to those saving lives while attempting to comply with the rules of practice. Physicians often discover—through real cases and the lens of regulatory expectations—that even well-intentioned informal help can be reinterpreted as stepping outside mandated professional boundaries, and seemingly harmless actions can be construed as deviations from required practice standards specifically outlined in Title 13, Chapter 35, Subchapters 7.1A of the New Jersey Administrative Code. Title 45, "Professions and Occupations," of the New Jersey code governs the practice of medicine, nursing, optometry, pharmacy, and many other professional occupations. Section 9 specifically addresses the state board of medical examiners and allows for the creation of rules and regulations in Section 45:9-5.3. These regulations can be found in the New Jersey Administrative Code Title 13, Chapter 35. While broad in scope, Chapter 35 contains a subchapter dedicated to the administration and dispensing of prescription drugs. Such knowledge will arm physicians with the tools they need to prevent a negative outcome if a medical board complaint is filed. Likewise, attorneys must be familiar with these regulatory requirements when advising and defending providers. In New Jersey, N.J.A.C. Section 13:35-7.1A(a) requires that a practitioner conduct an examination and appropriately document the same within the medical record before dispensing drugs or issuing prescriptions. The examination must include an "appropriate history and physical examination," a diagnosis based upon the examination and any testing consistent with good medical care, the formulation of a therapeutic plan discussed with the patient, and the availability of appropriate follow-up care. There are only six exceptions to this requirement: In admission orders for a newly hospitalized patient For a patient of another physician for whom the practitioner is taking calls For continuation medications on a short-term basis for a new patient prior to the patient's first appointment For an established patient who, based on sound medical practice, the physician believes does not require a new examination before issuing a new prescription For a patient examined by a healthcare professional who is in collaborative practice with the practitioner When treatment is provided by a practitioner for an emergency medical condition Emergencies are also limited to situations where someone's health is in serious jeopardy, there is serious impairment to bodily functions, or serious dysfunction of any bodily organ or part. During the COVID-19 pandemic, then New Jersey Governor Phil Murphy issued an executive order declaring a public health emergency and a state of emergency that allowed authorized prescribers to prescribe Schedule II controlled dangerous substances via telemedicine. The order was terminated when he left office earlier this year and the state reverted to the requirement of an initial in-person examination and quarterly in-person visits. With this return to prior regulatory requirements, practitioners subject to the jurisdiction of the board of medical examiners may benefit from a refresher on the regulatory limitations on their practice now that the pandemic-era flexibilities have ended. This new requirement may create confusion for prescribers and lead to casual prescribing of medication in violation of the regulations, even in the setting of recurrent telemedicine appointments as noted in the example above. Casual prescribing can take many forms: filling a prescription request from a friend or family member without an examination or contemporary medical record; using telemedicine to expand your practice without proper in-person appointments or documentation in the medical record; failing to ensure appropriate follow-up care for a "one time" prescription; etc. Although not all board complaints end in a publicly available opinion, serious deviations from regulatory requirements can shine a light on practices that will require action by the board if a complaint is received. Consider the following cases: In October 2025, the board issued a final consent order in an administrative action where a doctor provided opioids without examination and his license was permanently revoked. In re Robert Dela Gente, D.O., N.J. State Bd. of Med. Exam'rs Oct. 21, 2025. Criminal charges were filed (though that is not always the case). In a September 2025 consent order, a physician was reprimanded for "prescribing opioids several months in advance without the proper patient follow-up..." and explained that they did so for "patients who can not pay for multiple visits to refill medications." In re A/an E. Schultz, M.D., N.J. State Bd. of Med. Exam'rs Sept. 25, 2025. Another physician was suspended and placed on probation in a consent order for prescribing three patients the weight-loss medication "Ozempic" via text messages through a website called "Push Health" and without any further communication with the patients or taking a medical history. In re Laura E. Purdy, M.D., N.J. State Bd. of Med. Exam'rs Aug. 29, 2025. A June 2025 interim consent order required a "full evaluation and assessment of [a physician's] general knowledge and skill, with specific emphasis on his knowledge of and ability to safely prescribe [controlled dangerous substances]" due to his failure to review a patient's prior medical history and medical record, assess and review the prescription monitoring program before prescribing CDS, and conduct random urine screens on a patient that tested positive for CDS upon admission to his practice because "he trusted the patient." In re Donald Oh, M.D., N.J. State Bd. of Med. Exam'rs June 2, 2025. Each of these examples demonstrate a failure to follow strict procedure regardless of the intention. Failing to follow procedure secondary to good intentions, such as considering a patient's financial constraints, trust in the patient, or utilizing a new telemedicine service platform, will not be a defense to a board complaint. Especially when practicing via telemedicine, practitioners must ensure they are adhering to the appropriate regulatory standard. A provider who calls in a prescription for a traveling friend or family member or agrees to prescribe medication for individuals using the newest phone app will have a hard time meeting the requirements of N.J.A.C. Section 13:35-7.1A. Even if a history was taken, a "therapeutic plan" was created, and "follow up care" was provided, the prescriber would still not be in compliance with the regulation without an in-person examination. In our opening hypothetical, the prescriber's behavior did not change between December and March; however, the legal shift in the regulatory landscape made once acceptable behavior a violation as a required examination did not occur. When complaints are made with regard to informal prescribing, the board has discretion to employ measures to encourage compliance in lieu of formal proceedings such as a private, written warning; suspending fines subject to continuing compliance; medical or professional treatment as may be necessary; medical or diagnostic testing and monitoring; skills assessment; corrective training; participation in outreach programming; or contribution to the consumer fraud protection fund. The lesson for health care practitioners is that regular review of the regulatory requirements can ensure compliance and that casual prescribing may be in violation of state regulations if the necessary components are not met. Even compliant providers who had not conducted an in-person examination for telemedicine patients during the COVID-19 emergency would be in violation of the regulations as of January 2026 for the same practice. Practitioners should be diligent in adhering to the prescribing rules to avoid sanctions related to casual care. Likewise, attorneys advising or defending practitioners before the board must be aware of the in-person examination requirements for prescribing in New Jersey whether the care in question took place in-person or in a telemedicine setting. Reprinted with permission from the April 22, 2026 issue of the New Jersey Law Journal. ©2026 ALM Media Properties, LLC. Further duplication without permission is prohibited. All rights reserved.